References
- Logan R FA, Gillon J, Ferrington C, Ferguson A. Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut 1981; 22: 383–387
- O'Morain C, Segal A W, Levi A J. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J 1984; 288: 1859–1862
- Elson C O, Layden T J, Nemchausky B A, Rosenberg J L, Rosenberg I H. An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci 1980; 25: 42–48
- Muller J M, Keller H W, Erasmi H, Pichlmaier H. Total parenteral nutrition as the sole therapy in Crohn's disease—a prospective study. Br J Surg 1983; 70: 40–43
- Greenberg G R, Fleming C R, Jeejeebhoy K N, Rosenberg I H, Sales D, Tremaine W J. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988; 29: 1309–1315
- Alun Jones V. Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn's disease. Dig Dis Sci 1987; 32: 100S–107S
- Jewell D P, Kettlewell M GW. Split ileostomy for Crohn's colitis. Current management of inflammatory bowel disease, T M Bayless. BC Decker, Toronto 1989; 294–296
- Alun Jones V, Dickinson R J, Workman E, Wilson A J, Freeman A H, Hunter J O. Crohn's disease: maintenance of remission by diet. Lancet 1985; 2: 177–180
- Mayberry J F, Rhodes J. Epidemiological aspects of Crohn's disease: a review of the literature. Gut 1984; 25: 886–899
- Falchuk K R, Isselbacher K J. Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Characterization of the antibody response. Gastroenterology 1976; 70: 5–8
- Knoflach P, Park B H, Cunningham R, Weiser M M, Albini B. Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease. Gastroenterology 1987; 92: 479–485
- Main J, McKenzie H, Yeaman G R, et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. Br Med J 1988; 297: 1105–1106
- McKenzie H, Main J, Pennington C R, Parratt D. Antibodies to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536–538
- Barnes R MR, Allan S, Taylor-Robinson C H, Finn R, Johnson P M. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease?. Int Arch Allergy Appl Immunol 1990; 92: 9–15
- Crook W G. The yeast connection. 2nd ed. Pelican Publishing, Gretna, La.USA 1984
- Pettit S H, Holbrook I B, Irving M H. Comparison of clinical scores and acute phase proteins in the assessment of acute Crohn's disease. Br J Surg 1985; 72: 1013–1016
- Van Hees P AM, Van Elteren P H, Van Lier H JJ, Van Tongeren J HM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21: 279–286
- Best W R, Becktel J M, Singleton J W, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439–444
- Ursing B, Alm T, Barany F, et al. A comparative study of metronidazole and sulphasalazine for active Crohn's disease, the Cooperative Crohn's Disease Study in Sweden. II. Result. Gastroenterology 1982; 83: 550–562
- Elliott P R, Lennard-Jones J E, Hathaway N. Simple index of Crohn's disease activity (letter). Lancet 1980; 1: 876
- Maratka Z. Crohn's disease activity indexes: need for distinguishing activity from severity. Hepatogastroenterology 1981; 28: 187–189
- Malchow H, Ewe K, Brandes J W, et al. European Co-operative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249–266
- Mekhjian H S, Switz D M, Melnyk C S, Rankin G B, Brooks R K. Clinical features and natural history of Crohn's disease. Gastroenterology 1979; 77: 898–906
- James S P, Strober W, Ouinn T C, Danovitch S H. Crohn's disease. New concepts of pathogenesis and current approaches to treatment. Dig Dis Sci 1987; 32: 1297–1310
- Hodgson H JF, Jewell D P. Immunology of inflammatory bowel disease. Bailliere's Clin Gastroenterol 1987; 1: 531–545
- Domer J D, Stashak P W, Elkins K, Prcscott B, Caldes G, Baker P J. Separation of immunomodulatory effects on mannan from Candida albicans into stimulatory and suppressive components. Cell Immunol 1986; 101: 403–414
- Daniel T M, Janicki B W. Mycobacterial antigens: a review of their isolation, chemistry and immunological properties. Microbiol Rev 1978; 42: 84–113
- Chiodoni R J, Van Kruiningen H J, Merkal R S, Thayer W R, Coutu J A. Characteristics of an unclassified mycobacterium species isolated from patients with Crohn's disease. J Clin Microbiol 1984; 20: 966–971
- Collins J, Beaman B, Arthur M, Gitnick G. Isolation of mycobacteria from intestinal tissues. Gastroenterology 1986; 90: 1377
- Shaffer J L, Hughes S, Linaker B D, Baker R D, Turnberg L A. Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 1984; 25: 203–205
- Elliott P R, Burnham W R, Berghouse L M, Lennard-Jones J E, Langman M J. Sulphadoxine-pyrimethamine therapy in Crohn's disease. Digestion 1982; 23: 132–134
- Morgan K L. Johone's and Crohn's. Chronic inflammatory bowel disease of infectious aetiology. Lancet 1987; 1: 1017–1019
- Sanderson J D, Moss M, Malik Z, Tizard M, Green E P, Hermon Taylor J. Polymerase chain reaction detects mycobacterium paratuberculosis in Crohn's disease tissue extracts. Gut 1991; 32: A572